Venrock Adviser, LLC Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001615982

What is a 13F filing? Who files one and when · What 13F filings can't tell you

SmallFocusedHealth TiltHigh Turnover how tags are computed

Q3 2023 · 37 positions · Total reported value $949.95M · Top-10 concentration 62.2% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 35.1% · 4 new · 5 cut · 4 exited

Active Share (vs S&P 500): 100.0% · vs QQQ: 100.0% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +24.9% · vs SPY +10.0% · Prev Value $2.68B — last quarter positions weighted by this quarter price moves · ranking

In its Q3 2023 13F filing, Venrock Adviser, LLC disclosed 37 equity positions with a combined reported value of $949.95M. The filing implies a focused portfolio: its ten largest positions account for 62.2% of reported value. HoldingsHub classifies the profile as Small / Focused / Health Tilt / High Turnover.

The largest disclosed positions as of Q3 2023 were APGE ($180.91M), RYZB ($89.17M), VRDN ($47.29M). By sector, the heaviest allocations are Health Care 51.5%, Other 48.5%.

Versus the prior quarter, Venrock Adviser, LLC opened 4 new positions, trimmed 5 and fully exited 4, a turnover rate of 35.1% of positions.

The largest new positions opened in Q3 2023 were APGE ($180.91M), RYZB ($89.17M), VRDN ($47.29M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q3 2023)

  • APGE APOGEE THERAPEUTICS INC · $180.91M
  • RYZB RAYZEBIO INC · $89.17M
  • VRDN VIRIDIAN THERAPEUTICS INC · $47.29M
  • COGT COGENT BIOSCIENCES INC · $45.67M
  • TSHA TAYSHA GENE THERAPIES IN · $45.64M
  • MRUS MERUS N V · $40.70M
  • ELVN ENLIVEN THERAPEUTICS INC · $40.36M
  • FDMT 4D MOLECULAR THERAPEUTICS IN · $38.19M

Fully Exited (vs previous quarter)

No tracked position was fully exited this quarter.

Insider Transactions (Form 4)

Latest Venrock Adviser, LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Venrock Adviser, LLC is an SEC-registered 13F filer based in New York, NY, United States. As of Q2 2026 it reported 33 US equity positions with a combined value of $3.30B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Firm Snapshot

  • Headquarters: NEW YORK, NY, United States
  • SEC registration: 801-79382 (status: Approved), registered 2014-04-09
  • Regulatory AUM (Form ADV): $4.50B as of 2026-04-28
  • Client mix (by RAUM): pension and profit-sharing plans 100%
  • Manages 7 private funds, of which 1 hedge funds

Portfolio Structure

  • 33 positions · $3.30B reported value (Q2 2026)
  • Top 10 holdings = 80.4% of reported value
  • Largest position: APGE (APOGEE THERAPEUTICS INC) at 34.2%
  • Average position size: $99.94M

Sector Tilt

  • Health Care 65.7%
  • Financials 0.1%
  • (classified holdings cover 66% of value)

Quarterly Activity

  • Q2 2026: 4 new, 5 added, 5 reduced, 4 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Health Care 51.5%
Other 48.5%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 8.49M $180.91M 19.04%
19.04%
New
2 4.02M $89.17M 9.39%
9.39%
New
3 3.08M $47.29M 4.98%
4.98%
New
4 4.68M $45.67M 4.81%
4.81%
New
5 14.44M $45.64M 4.80%
4.80%
New
6 1.73M $40.70M 4.29%
4.29%
New
7 2.95M $40.36M 4.25%
4.25%
New
8 3.00M $38.19M 4.02%
4.02%
New
9 1.56M $32.63M 3.44%
3.44%
New
10 1.97M $30.03M 3.16%
3.16%
New
11 2.92M $28.09M 2.96%
2.96%
New
12 2.74M $27.58M 2.90%
2.90%
New
13 2.04M $27.40M 2.88%
2.88%
New
14 7.18M $27.16M 2.86%
2.86%
New
15 1.09M $24.99M 2.63%
2.63%
New
16 2.07M $23.80M 2.51%
2.51%
New
17 2.62M $23.46M 2.47%
2.47%
New
18 2.17M $19.48M 2.05%
2.05%
New
19 2.11M $19.24M 2.03%
2.03%
New
20 3.09M $15.55M 1.64%
1.64%
New
21 11.33M $14.39M 1.51%
1.51%
New
22 5.66M $14.09M 1.48%
1.48%
New
23 2.14M $12.96M 1.36%
1.36%
New
24 927.71K $12.68M 1.33%
1.33%
New
25 6.57M $9.86M 1.04%
1.04%
New
26 5.30M $9.07M 0.95%
0.95%
New
27 864.33K $8.79M 0.93%
0.93%
New
28 3.42M $7.46M 0.79%
0.79%
New
29 1.04M $7.13M 0.75%
0.75%
New
30 2.21M $6.85M 0.72%
0.72%
New
31 288.95K $5.01M 0.53%
0.53%
New
32 515.00K $4.53M 0.48%
0.48%
New
33 295.03K $3.61M 0.38%
0.38%
New
34 924.17K $3.61M 0.38%
0.38%
New
35 77.04K $951.47K 0.10%
0.10%
New
36 268.53K $904.95K 0.10%
0.10%
New
37 1.43M $682.71K 0.07%
0.07%
New

FAQ

What did Venrock Adviser, LLC buy in 2023-Q3?

In its 2023-Q3 13F filing, Venrock Adviser, LLC reported 37 equity positions worth $949.95M in aggregate; its largest disclosed positions were APGE ($180.91M), RYZB ($89.17M), VRDN ($47.29M).

How large is Venrock Adviser, LLC's portfolio?

Venrock Adviser, LLC reported $949.95M of long equity holdings across 37 positions as of 2023-Q3. Top-10 holdings account for 62.2% of reported value.

What is Venrock Adviser, LLC's investment style?

HoldingsHub classifies the portfolio as Small / Focused / Health Tilt / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/venrock-adviser/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →